Article
Tumor molecular profiling of NSCLC patients using next generation sequencing.
Oncology reports - 1 Dec 2017
Tsoulos Nikolaos, Papadopoulou Eirini, Metaxa-Mariatou Vasiliki, Tsaousis Georgios, Efstathiadou Chrisoula, Tounta Georgia, Scapeti Aikaterini, Bourkoula Eugenia, Zarogoulidis Pavlos, Pentheroudakis George, Kakolyris Stylianos, Boukovinas Ioannis, Papakotoulas Pavlos, Athanasiadis Elias, Floros Theofanis, Koumarianou Anna, Barbounis Vasileios, Dinischiotu Anca, Nasioulas George
Abstract excerpt
Non‑small cell lung cancer (NSCLC) is the most common type of lung cancer and a tumor with a broad spectrum of targeted therapies already available or in clinical trials. Thus, molecular characterization of the tumor using next generation sequencing (NGS) technology, has become a key tool for facilitating treatment decisions and the clinical management of NSCLC patients. The performance of a custom 23 gene...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.